Related Experiment Video
Updated: Feb 3, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis
Sabrina Daniela da Silva1,2, Bin Xu1, Mariana Maschietto3
1Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Departments of Medicine, Oncology, and Pharmacology and Therapeutics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Abstract:
TRAF2, a RING finger adaptor protein, plays an important function in tumor necrosis factor (TNF)- and TNF-like weak inducer of apoptosis (TWEAK)-dependent signaling, in particular during inflammatory and immune responses. We identified a functional interaction of TRAF2 with focal adhesion (FA) signaling involving the focal adhesion kinase (FAK) in the regulation of cell susceptibility to anoikis. Comparison of TRAF2-proficient (TRAF2+/+) versus TRAF2-deficient (TRAF2-/-), and FAK-proficient (FAK+/+) versus FAK-deficient (FAK-/-) mouse embryonic fibroblasts and their matched reconstituted cells demonstrated that TRAF2 interacts physically with the N-terminal portion of FAK and colocalizes to cell membrane protrusions. This interaction was found to be critical for promoting resistance to cell anoikis. Similar results were confirmed in the human breast cancer cell line MDA-MB-231, where TRAF2 and FAK downregulation promoted cell susceptibility to anoikis. In human breast cancer tissues, genomic analysis of The Cancer Genome Atlas database revealed coamplification of TRAF2 and FAK in breast cancer tissues with a predictive value for shorter survival, further supporting a potential role of TRAF2-FAK cooperative signaling in cancer progression.
Insights
Tumor necrosis factor receptor-associated factor 2 (TRAF2) interacts with focal adhesion kinase (FAK) to prevent anoikis, a form of cell death. This TRAF2-FAK signaling is crucial for cancer progression and shorter survival in breast cancer patients.
Area of Science:
- Cell biology
- Molecular signaling
- Cancer research
Background:
- Tumor necrosis factor receptor-associated factor 2 (TRAF2) is vital in inflammatory and immune responses via TNF and TWEAK signaling.
- Anoikis is a form of programmed cell death triggered by the loss of cell-matrix adhesion.
- Focal adhesion kinase (FAK) is a key regulator of cell adhesion and survival.
Purpose of the Study:
- To investigate the functional interaction between TRAF2 and focal adhesion (FA) signaling, specifically involving FAK.
- To determine the role of the TRAF2-FAK interaction in regulating anoikis.
- To explore the clinical relevance of TRAF2 and FAK coamplification in human breast cancer.
Main Methods:
- Utilized TRAF2-proficient/deficient and FAK-proficient/deficient mouse embryonic fibroblasts.
- Performed co-localization studies and physical interaction assays.
- Analyzed The Cancer Genome Atlas database for genomic alterations in human breast cancer tissues.
Main Results:
- TRAF2 physically interacts with the N-terminal region of FAK and co-localizes to cell membrane protrusions.
- This TRAF2-FAK interaction confers resistance to anoikis in both mouse and human cells.
- TRAF2 and FAK downregulation increases susceptibility to anoikis.
- Coamplification of TRAF2 and FAK in breast cancer tissues predicts shorter patient survival.
Conclusions:
- TRAF2 and FAK form a functional complex that inhibits anoikis.
- This TRAF2-FAK signaling pathway plays a significant role in promoting cell survival and potentially cancer progression.
- The coamplification of TRAF2 and FAK serves as a potential biomarker for poor prognosis in breast cancer.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
What is Cell Signaling?

